Please assess the completion status of the following clinical trial:

Trial Title: Fluorescence-guided Resection in Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Caucasian female postmenopausal patients~* Patients with histologically confirmed primary palpable and nonpalpable breast cancer sized up to 5 cm (T1 - T2)~Exclusion Criteria:~* Suspicious lymphogenic metastases (cN1-3)~* Acute or chronic hepatic diseases~* Manifest renal diseases with renal dysfunction~* Relevant cardiac disease~* Preceding therapy of breast tumour under investigation~* Patients with multiple attempts of hook-wire placement in preparation of surgery~* Dementia or psychic condition that might interfere with the ability to understand the study and thus give a written informed consent~* Simultaneous participation in another clinical study or participation in another clinical study in the 30 days directly preceding treatment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PD L 506 2nd dose (Type: ACTIVE_COMPARATOR): Different dosage
- PD L 506 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).